Syntara Limited (ASX:SNT)
0.0320
-0.0010 (-3.03%)
Jan 30, 2026, 3:47 PM AEST
Syntara Revenue
In the fiscal year ending June 30, 2025, Syntara had annual revenue of 7.30M AUD with 26.61% growth. Syntara had revenue of 2.14M in the quarter ending June 30, 2025, a decrease of -55.03%.
Revenue
7.30M
Revenue Growth
+26.61%
P/S Ratio
7.38
Revenue / Employee
347.52K
Employees
21
Market Cap
53.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7.30M | 1.53M | 26.61% |
| Jun 30, 2024 | 5.76M | -468.00K | -7.51% |
| Jun 30, 2023 | 6.23M | -9.52M | -60.45% |
| Jun 30, 2022 | 15.76M | -7.87M | -33.31% |
| Jun 30, 2021 | 23.63M | 11.01M | 87.28% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 124.04M |
| Vita Life Sciences | 85.60M |
| Medical Developments International | 39.06M |
| Little Green Pharma | 38.49M |
| Next Science | 33.66M |
| IDT Australia | 19.77M |
| ECS Botanics Holdings | 19.36M |
| Peak Processing | 15.49M |